Today’s top gainers include the company Incyte Corporation (NASDAQ:INCY) which is in the industry Biotechnology, gaining -0.51% today. In the last week its performance is -1.66%, and 4.58% for the past quarter. Currently, Incyte Corporation, INCY has a target price of 92.43, so today’s gain of -0.51% is a significant step towards its target price. The GAP today is therefore 0.91%.
Incyte Corporation (NASDAQ:INCY), has a market cap of 15375.29, and is based in USA. Insider ownership is at 0.20%, and institutional ownership is 99.00%.
At the current price of 82.14, it has a dividend yield of *TBA, and its target price is 92.43. This is with a profit margin of 5.70%, and total debt/equity of 0. Incyte Corporation (NASDAQ:INCY) has a P/E of 389.29, as well as a forward P/E of 62.18.
With a current EPS of 0.21, and a forecasted EPS growth for next year at 2902.27%,Incyte Corporation (NASDAQ:INCY) has had a EPS growth for the past five years at 16.40%. For the next five years EPS growth is projected to be 38.70%.
Performance for the year is -29.12%. Since its IPO date on 11/4/1993, the total performance to date is -24.26%.
Volume today for Incyte Corporation (NASDAQ:INCY), is 735900, while its average volume is 1112.02. Whilst the total gain today was -0.51%, it did have a day high of -6.53%.
Volatility for this week has been at 2.99%, and 4.07% for the month. The 52-week low for Incyte Corporation, INCY has been 49.35%, while the 52-week-high has reached -38.53%.
Looking at its return of investments, which is 6.30%, and its return on assets is 4.90%. Incyte Corporation (NASDAQ:INCY) has an operating margin of 10.90%. With a sales growth of 65.40% quarter over quarter. Bearing in mind that Incyte Corporation, INCY is in the sector Healthcare, its long-term debt/equity is 2.76, and has a current ratio of 4.7 and 4.7 for quick ratio.
So what is the value of Incyte Corporation? Well its PEG is 10.06, and the P/S is 17.92, along with a P/B of 67.33. Meanwhile it has a p/cash of 18.97.